Analgesics is one of 60 small molecule programs targeting Sedation. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
350 competitors in Treatment
Biltricide
Dexilant
Alfenta
Niclocide
Minipress
Valium
Clomid
Aurlumyn
Lotemax
Norpramin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details